Does EVEROLIMUS Cause Metastatic neoplasm? 40 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 40 reports of Metastatic neoplasm have been filed in association with EVEROLIMUS (EVEROLIMUS). This represents 0.1% of all adverse event reports for EVEROLIMUS.
40
Reports of Metastatic neoplasm with EVEROLIMUS
0.1%
of all EVEROLIMUS reports
19
Deaths
6
Hospitalizations
How Dangerous Is Metastatic neoplasm From EVEROLIMUS?
Of the 40 reports, 19 (47.5%) resulted in death, 6 (15.0%) required hospitalization, and 1 (2.5%) were considered life-threatening.
Is Metastatic neoplasm Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVEROLIMUS. However, 40 reports have been filed with the FAERS database.
What Other Side Effects Does EVEROLIMUS Cause?
Death (5,090)
Malignant neoplasm progression (3,789)
Diarrhoea (3,061)
Fatigue (2,946)
Stomatitis (2,692)
Nausea (2,079)
Dyspnoea (1,925)
Drug ineffective (1,837)
Pyrexia (1,664)
Decreased appetite (1,633)
What Other Drugs Cause Metastatic neoplasm?
BEVACIZUMAB (133)
TRASTUZUMAB (120)
CAPECITABINE (102)
PACLITAXEL (102)
CARBOPLATIN (89)
LEUPROLIDE (84)
DOCETAXEL (72)
ADALIMUMAB (71)
RANITIDINE (71)
DENOSUMAB (68)
Which EVEROLIMUS Alternatives Have Lower Metastatic neoplasm Risk?
EVEROLIMUS vs EVOLOCUMAB
EVEROLIMUS vs EXELON
EVEROLIMUS vs EXEMESTANE
EVEROLIMUS vs EXENATIDE
EVEROLIMUS vs EXFORGE